Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – Anemia that develops in hepatitis C virus (HCV) patients during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research…
NEW YORK (Reuters Health) – Vaccinating pregnant women against influenza is a highly effective way of keeping their infants from being hospitalized with influenza in the first six…
NEW YORK (Reuters Health) – Initiating mediastinal nodal staging of suspected lung cancer with endosonography, followed by surgical staging (mediastinoscopy) if needed, improves the detection of metastases and…
NEW YORK (Reuters Health) – There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today…
NEW YORK (Reuters Health) – Despite declining use, perineal radical prostatectomy (PRP) yields outcomes that are equal to, or better than, those of retropubic radical prostatectomy (RRP) and…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Extended Meeting Coverage. In this edition, we bring you extended coverage of the DEFINE trial, featuring…
NEW YORK (Reuters Health) – Outcomes of cryoablation of small renal masses are similar whether the procedure is performed surgically or percutaneously, according the results of a meta-analysis…
NEW YORK (Reuters Health) – In terms of overall survival, carboplatin plus the oral fluoropyrimidine derivative S-1 is as effective as carboplatin plus paclitaxel in chemotherapy-naive patients with…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 4. Our fourth and final daily wrap-up features highlights from the key late breaking trials,…
